Mary O’Neill

522 total citations
9 papers, 297 citations indexed

About

Mary O’Neill is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mary O’Neill has authored 9 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Genetics. Recurrent topics in Mary O’Neill's work include Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Mary O’Neill is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Mary O’Neill collaborates with scholars based in United Kingdom, United States and Brazil. Mary O’Neill's co-authors include Noreen E. Murray, Karen Murray, Nereide Stela Santos-Magalhães, Ana Maria dos Anjos Carneiro-Leão, Alastair M. Thompson, Virginia Appleyard, David W. Melton, Alastair M. Thompson, F. Paulin and Angela Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Journal of Molecular Biology.

In The Last Decade

Mary O’Neill

9 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary O’Neill United Kingdom	8	140	92	83	51	42	9	297
Chao Shi China	10	252 1.8×	95 1.0×	39 0.5×	60 1.2×	70 1.7×	28	410
Soo J. Park Australia	13	67 0.5×	70 0.8×	36 0.4×	30 0.6×	81 1.9×	49	470
Anja Drescher Austria	8	342 2.4×	110 1.2×	74 0.9×	51 1.0×	147 3.5×	10	558
Liwei Wu China	11	236 1.7×	49 0.5×	12 0.1×	36 0.7×	66 1.6×	34	329
JaeJin Choi South Korea	8	126 0.9×	19 0.2×	24 0.3×	9 0.2×	47 1.1×	9	219
Le Cheng China	11	189 1.4×	16 0.2×	27 0.3×	62 1.2×	72 1.7×	23	369
Margarida O. Krause Canada	11	303 2.2×	32 0.3×	42 0.5×	75 1.5×	98 2.3×	33	407
Pedro Rodríguez Colombia	7	224 1.6×	26 0.3×	23 0.3×	27 0.5×	23 0.5×	23	344
María Ángeles Corral-Rodríguez Spain	10	139 1.0×	10 0.1×	17 0.2×	44 0.9×	27 0.6×	12	322
Pavel Němec Czechia	9	158 1.1×	11 0.1×	51 0.6×	9 0.2×	56 1.3×	38	319

Countries citing papers authored by Mary O’Neill

Since Specialization

Citations

This map shows the geographic impact of Mary O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary O’Neill more than expected).

Fields of papers citing papers by Mary O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary O’Neill. The network helps show where Mary O’Neill may publish in the future.

Co-authorship network of co-authors of Mary O’Neill

This figure shows the co-authorship network connecting the top 25 collaborators of Mary O’Neill. A scholar is included among the top collaborators of Mary O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary O’Neill. Mary O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

O’Neill, Mary, et al.. (2012). The aromatase inhibitor letrozole enhances the effect of doxorubicin and docetaxel in an MCF7 cell line model. ZooKeys. 9 indexed citations

Paulin, F., Mary O’Neill, Andrew Cassidy, et al.. (2008). MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism. BMC Cancer. 8(1). 281–281. 40 indexed citations

O’Neill, Mary, Karen Murray, F. Paulin, et al.. (2008). Seliciclib (CYC202, R‐roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. International Journal of Cancer. 124(2). 465–472. 43 indexed citations

O’Neill, Mary, Karen Murray, Nereide Stela Santos-Magalhães, et al.. (2005). Usnic acid: a non-genotoxic compound with anti-cancer properties. Anti-Cancer Drugs. 16(8). 805–809. 104 indexed citations

O’Neill, Mary, et al.. (2003). p53 and a human premature ageing disorder. Mechanisms of Ageing and Development. 124(5). 599–603. 5 indexed citations

O’Neill, Mary, et al.. (2003). Characterization of Premature Liver Polyploidy in Dna Repair ( Ercc1 )–Deficient Mice. Hepatology. 38(4). 958–966. 29 indexed citations

O’Neill, Mary, Lynn M. Powell, & Noreen E. Murray. (2001). Target recognition by EcoKI: the recognition domain is robust and restriction-deficiency commonly results from the proteolytic control of enzyme activity11Edited by J. Karn. Journal of Molecular Biology. 307(3). 951–963. 16 indexed citations

O’Neill, Mary, David T. F. Dryden, & Noreen E. Murray. (1998). Localization of a protein–DNA interface by random mutagenesis. The EMBO Journal. 17(23). 7118–7127. 21 indexed citations

O’Neill, Mary, Angela Chen, & Noreen E. Murray. (1997). The restriction–modification genes of Escherichia coli K-12 may not be selfish: They do not resist loss and are readily replaced by alleles conferring different specificities. Proceedings of the National Academy of Sciences. 94(26). 14596–14601. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact